101 related articles for article (PubMed ID: 12960413)
21. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer.
Rundle A; Tang D; Hibshoosh H; Estabrook A; Schnabel F; Cao W; Grumet S; Perera FP
Carcinogenesis; 2000 Jul; 21(7):1281-9. PubMed ID: 10874004
[TBL] [Abstract][Full Text] [Related]
22. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
Stern MC; Johnson LR; Bell DA; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
[TBL] [Abstract][Full Text] [Related]
23. Bladder tumor contains higher N7-methylguanine levels in DNA than adjacent normal bladder epithelium.
Saad AA; O'Connor PJ; Mostafa MH; Metwalli NE; Cooper DP; Margison GP; Povey AC
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):740-3. PubMed ID: 16614117
[TBL] [Abstract][Full Text] [Related]
24. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
[TBL] [Abstract][Full Text] [Related]
25. Aromatic DNA adducts in larynx biopsies and leukocytes.
Szyfter K; Hemminki K; Szyfter W; Szmeja Z; Banaszewski J; Yang K
Carcinogenesis; 1994 Oct; 15(10):2195-9. PubMed ID: 7955053
[TBL] [Abstract][Full Text] [Related]
26. Chronic, topical administration of 4-aminobiphenyl induces tissue-specific DNA adducts in mice.
Underwood PM; Zhou Q; Jaeger M; Reilman R; Pinney S; Warshawsky D; Talaska G
Toxicol Appl Pharmacol; 1997 Jun; 144(2):325-31. PubMed ID: 9194416
[TBL] [Abstract][Full Text] [Related]
27. Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies.
Airoldi L; Orsi F; Magagnotti C; Coda R; Randone D; Casetta G; Peluso M; Hautefeuille A; Malaveille C; Vineis P
Carcinogenesis; 2002 May; 23(5):861-6. PubMed ID: 12016161
[TBL] [Abstract][Full Text] [Related]
28. Polycyclic aromatic hydrocarbon--DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lung.
van Schooten FJ; Hillebrand MJ; van Leeuwen FE; van Zandwijk N; Jansen HM; den Engelse L; Kriek E
Carcinogenesis; 1992 Jun; 13(6):987-93. PubMed ID: 1600621
[TBL] [Abstract][Full Text] [Related]
29. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects.
Matullo G; Palli D; Peluso M; Guarrera S; Carturan S; Celentano E; Krogh V; Munnia A; Tumino R; Polidoro S; Piazza A; Vineis P
Carcinogenesis; 2001 Sep; 22(9):1437-45. PubMed ID: 11532866
[TBL] [Abstract][Full Text] [Related]
30. DNA adducts of ortho-toluidine in human bladder.
Böhm F; Schmid D; Denzinger S; Wieland WF; Richter E
Biomarkers; 2011 Mar; 16(2):120-8. PubMed ID: 21117897
[TBL] [Abstract][Full Text] [Related]
31. Differences in aromatic-DNA adduct levels between alveolar macrophages and subpopulations of white blood cells from smokers.
Godschalk RW; Maas LM; Van Zandwijk N; van 't Veer LJ; Breedijk A; Borm PJ; Verhaert J; Kleinjans JC; van Schooten FJ
Carcinogenesis; 1998 May; 19(5):819-25. PubMed ID: 9635869
[TBL] [Abstract][Full Text] [Related]
32. DNA adduct assay in cervical epithelium.
Simons AM; Phillips DH; Coleman DV
Diagn Cytopathol; 1994; 10(3):284-8. PubMed ID: 8050337
[TBL] [Abstract][Full Text] [Related]
33. DNA adducts and lung cancer risk: a prospective study.
Peluso M; Munnia A; Hoek G; Krzyzanowski M; Veglia F; Airoldi L; Autrup H; Dunning A; Garte S; Hainaut P; Malaveille C; Gormally E; Matullo G; Overvad K; Raaschou-Nielsen O; Clavel-Chapelon F; Linseisen J; Boeing H; Trichopoulou A; Trichopoulos D; Kaladidi A; Palli D; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita HB; Peeters PH; Kumle M; Gonzalez CA; Martinez C; Dorronsoro M; Barricarte A; Navarro C; Quiros JR; Berglund G; Janzon L; Jarvholm B; Day NE; Key TJ; Saracci R; Kaaks R; Riboli E; Vineis P
Cancer Res; 2005 Sep; 65(17):8042-8. PubMed ID: 16140979
[TBL] [Abstract][Full Text] [Related]
34. Multiple DNA adducts in lymphocytes of smokers and nonsmokers determined by 32P-postlabeling analysis.
Jahnke GD; Thompson CL; Walker MP; Gallagher JE; Lucier GW; DiAugustine RP
Carcinogenesis; 1990 Feb; 11(2):205-11. PubMed ID: 2105856
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of cigarette smoke-related lipophilic DNA adducts in rat tissues by dietary oltipraz.
Arif JM; Gairola CG; Glauert HP; Kelloff GJ; Lubet RA; Gupta RC
Carcinogenesis; 1998 Aug; 19(8):1515-7. PubMed ID: 9744551
[TBL] [Abstract][Full Text] [Related]
36. BPDE-like DNA adduct level in oral tissue may act as a risk biomarker of oral cancer.
Chuang CY; Tung JN; Su MC; Wu BC; Hsin CH; Chen YJ; Yeh KT; Lee H; Cheng YW
Arch Oral Biol; 2013 Jan; 58(1):102-9. PubMed ID: 22809837
[TBL] [Abstract][Full Text] [Related]
37. DNA adduct levels of 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) in tissues of cynomolgus monkeys after single or multiple dosing.
Snyderwine EG; Schut HA; Sugimura T; Nagao M; Adamson RH
Carcinogenesis; 1994 Dec; 15(12):2757-61. PubMed ID: 8001231
[TBL] [Abstract][Full Text] [Related]
38. Detection of DNA adducts in human nasal mucosa tissue by 32P-postlabeling analysis.
Peluso M; Amasio E; Bonassi S; Munnia A; Altrupa F; Parodi S
Carcinogenesis; 1997 Feb; 18(2):339-44. PubMed ID: 9054626
[TBL] [Abstract][Full Text] [Related]
39. DNA adduct formation and tumorigenesis in mice during the chronic administration of 4-aminobiphenyl at multiple dose levels.
Poirier MC; Fullerton NF; Smith BA; Beland FA
Carcinogenesis; 1995 Dec; 16(12):2917-21. PubMed ID: 8603464
[TBL] [Abstract][Full Text] [Related]
40. Bulky DNA adducts as risk indicator of lung cancer in a Danish case-cohort study.
Bak H; Autrup H; Thomsen BL; Tjønneland A; Overvad K; Vogel U; Raaschou-Nielsen O; Loft S
Int J Cancer; 2006 Apr; 118(7):1618-22. PubMed ID: 16217769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
